Recent developments in health care delivery pose challenges for noncompete agreements. Litigation related to Covid-19 treatment guidance in New York highlights these issues. JostĮxplicitly including race or ethnicity as a factor in government allocation of resources raises legal concerns.
Aug 11Ĭombating Covid-19 Today and Tomorrow E.J. In this phase 1–2 study involving patients with relapsed or refractory myeloma, a bispecific antibody (teclistamab) that mediates T-cell activation and subsequent lysis of myeloma cells expressing B-cell maturation antigen induced responses in 63% of the patients, including a complete response in nearly 40%. Original Article Redirecting T Cells against Myeloma Cells P.The most trusted, influential source of new medical knowledge and clinical best practices in the world.
PUBLISHER PLUS REVIEWS LICENSE
Information and tools for librarians about site license offerings. Valuable tools for building a rewarding career in health care. The authorized source of trusted medical research and education for the Chinese-language medical community. The most advanced way to teach, practice, and assess clinical reasoning skills. Information, resources, and support needed to approach rotations - and life as a resident. The most effective and engaging way for clinicians to learn, improve their practice, and prepare for board exams. NEW! Peer-reviewed journal featuring in-depth articles to accelerate the transformation of health care delivery.Ĭoncise summaries and expert physician commentary that busy clinicians need to enhance patient care.
PUBLISHER PLUS REVIEWS TRIAL
The journal content will be of interest to healthcare professionals working in critical care, emergency medicine, acute medicine, anaesthesia, cardiology, paediatrics, neonatology, trauma and simulation.NEW! A digital journal for innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making. The only open access journal that is focused entirely on cardiac arrest and cardiopulmonary resuscitation. Systematic reviews, narrative reviews, scoping reviews, case reports and methods papers relating to cardiopulmonary resuscitation are also encouraged. Animal studies relating to cardiopulmonary resuscitation and post-resuscitation and papers relating to traumatic cardiac arrest and haemorrhagic shock are encouraged. The papers published deal with the aetiology, pathophysiology and prevention of cardiac arrest, resuscitation training and simulation, clinical resuscitation, and experimental resuscitation research. Aims & Scope Cross Resuscitation Plus, a companion title to the respected Resuscitation, is an open access quarterly international and interdisciplinary medical journal.